Zeke Capital Advisors’s Core Laboratories CLB Stock Holding History

Zeke Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,494	Closed	-$358K	–	286
2019 Q4	$358K	Hold	9,494	–	–	0.03%	438
2019 Q3	$443K	Hold	9,494	–	–	0.04%	382
2019 Q2	$496K	Sell	9,494 -70	-0.7%	-$4.11K	0.05%	358
2019 Q1	$659K	Sell	9,564 -114	-1%	-$7.64K	0.06%	296
2018 Q4	$577K	Buy	9,678 +367	+4%	+$31.7K	0.06%	305
2018 Q3	$1.08M	Buy	9,311 +284	+3%	+$32K	0.09%	228
2018 Q2	$1.14M	Buy	+9,027	New	+$1.1M	0.11%	165

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Zeke Capital Advisors's CLB Position: Q1 2020 in Review

Zeke Capital Advisors sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 9,494 shares — an estimated $358K sold.

Zeke Capital Advisors first reported a position in CLB in Q2 2018 and held it in 7 quarters. The position peaked at $1.14M in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Zeke Capital Advisors reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Zeke Capital Advisors sold 9,494 Core Laboratories shares in Q1 2020, an estimated $358K.
Zeke Capital Advisors first reported a position in Core Laboratories in Q2 2018 and held it in 7 quarters.
Zeke Capital Advisors's Core Laboratories position peaked at $1.14M in Q2 2018.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Zeke Capital Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.